Our mission is to become an industry leader in developing and commercializing bioactive peptides (small proteins). The exceptional antimicrobial and wound healing properties of these proprietary molecules qualify them for inclusion in a wide range of both pharmaceutical and consumer products.

Helix BioMedix Annual Shareholder Meeting
Thursday, May 15, 2008 at 8AM Pacific Daylight Time
Link to Webcast >>